advisorsecurities master

VIVSVivoSim Labs, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
23364
Ticker
VIVS
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2011-08-16
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
VIVS

Detail

Enriched 2026-08-14 20:47

Market cap
$1,160,380.98
Shares outstanding (class)
13,390,789
Shares outstanding (weighted)
3,494,071
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
15
Location
SAN DIEGO, CA
Description

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data